490 related articles for article (PubMed ID: 19793610)
1. Ovarian cancer.
Hennessy BT; Coleman RL; Markman M
Lancet; 2009 Oct; 374(9698):1371-82. PubMed ID: 19793610
[TBL] [Abstract][Full Text] [Related]
2. Advances in the management of epithelial ovarian cancer.
Berkenblit A; Cannistra SA
J Reprod Med; 2005 Jun; 50(6):426-38. PubMed ID: 16050567
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of risk factors for epithelial ovarian cancer recurrence].
Liu S; Liu JH; Huang H; Peng XP; Wang YM
Ai Zheng; 2003 Nov; 22(11):1197-200. PubMed ID: 14613652
[TBL] [Abstract][Full Text] [Related]
4. [Treatment and prognostic factors for stage IV epithelial ovarian cancer].
Wu M; Shen K; Lang J
Zhonghua Fu Chan Ke Za Zhi; 2000 Apr; 35(4):200-3. PubMed ID: 11776158
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of second-look laparotomy for surgically confirmed early-stage epithelial ovarian cancer: a multicenter retrospective study.
Sato N; Akahira J; Kitamura T; Aoki M; Yoshinaga K; Okamura C; Utsunomiya H; Shimizu T; Niikura H; Ito K; Okamura K; Yaegashi N
Int J Clin Oncol; 2003 Feb; 8(1):40-4. PubMed ID: 12601541
[TBL] [Abstract][Full Text] [Related]
6. Primary ovarian cancer.
Chow SN; Chen YP
Int Surg; 1987; 72(3):154-9. PubMed ID: 2824396
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
8. [Epithelial cancer of the ovary. An analysis of a prospective protocol].
Badía JI; Wild R; Barrena N; Mayerson D; Duarte I
Rev Chil Obstet Ginecol; 1991; 56(6):393-402; discussion 402-3. PubMed ID: 1669546
[TBL] [Abstract][Full Text] [Related]
9. [Epithelial ovarian cancer].
Hilpert F; Krause G; Venhoff L; Kühnle E; Schem C; Maass N
Ther Umsch; 2007 Jul; 64(7):375-80. PubMed ID: 17948754
[TBL] [Abstract][Full Text] [Related]
10. First-line treatment of advanced ovarian cancer: current research and perspectives.
Marchetti C; Pisano C; Facchini G; Bruni GS; Magazzino FP; Losito S; Pignata S
Expert Rev Anticancer Ther; 2010 Jan; 10(1):47-60. PubMed ID: 20014885
[TBL] [Abstract][Full Text] [Related]
11. Gynecological malignancies.
Schaebler DL; Schilder RJ; Young RC
Cancer Chemother Biol Response Modif; 1996; 16():564-91. PubMed ID: 8639401
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and management of epithelial ovarian cancer.
Bhoola S; Hoskins WJ
Obstet Gynecol; 2006 Jun; 107(6):1399-410. PubMed ID: 16738170
[TBL] [Abstract][Full Text] [Related]
13. Yolk sac tumours of the ovary: evaluation of clinicopathological features and prognostic factors.
Cicin I; Saip P; Guney N; Eralp Y; Ayan I; Kebudi R; Topuz E
Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):210-4. PubMed ID: 19419810
[TBL] [Abstract][Full Text] [Related]
14. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.
Veras E; Deavers MT; Silva EG; Malpica A
Am J Surg Pathol; 2007 May; 31(5):774-82. PubMed ID: 17460463
[TBL] [Abstract][Full Text] [Related]
15. Long-term results of a randomised phase III trial of weekly versus three-weekly paclitaxel/platinum induction therapy followed by standard or extended three-weekly paclitaxel/platinum in European patients with advanced epithelial ovarian cancer.
van der Burg ME; Onstenk W; Boere IA; Look M; Ottevanger PB; de Gooyer D; Kerkhofs LG; Valster FA; Ruit JB; van Reisen AG; Goey SH; van der Torren AM; ten Bokkel Huinink D; Kok TC; Verweij J; van Doorn HC
Eur J Cancer; 2014 Oct; 50(15):2592-601. PubMed ID: 25096168
[TBL] [Abstract][Full Text] [Related]
16. Future directions in the management of epithelial ovarian cancer.
Blagden S; Gabra H
Future Oncol; 2008 Jun; 4(3):403-11. PubMed ID: 18518765
[TBL] [Abstract][Full Text] [Related]
17. Advanced ovarian cancer: phase III randomized study of sequential cisplatin-topotecan and carboplatin-paclitaxel vs carboplatin-paclitaxel.
Hoskins P; Vergote I; Cervantes A; Tu D; Stuart G; Zola P; Poveda A; Provencher D; Katsaros D; Ojeda B; Ghatage P; Grimshaw R; Casado A; Elit L; Mendiola C; Sugimoto A; D'Hondt V; Oza A; Germa JR; Roy M; Brotto L; Chen D; Eisenhauer EA
J Natl Cancer Inst; 2010 Oct; 102(20):1547-56. PubMed ID: 20937992
[TBL] [Abstract][Full Text] [Related]
18. Frontline treatment of epithelial ovarian cancer.
Goh J; Mohan GR; Ladwa R; Ananda S; Cohen PA; Baron-Hay S
Asia Pac J Clin Oncol; 2015 Dec; 11 Suppl 6():1-16. PubMed ID: 26669253
[TBL] [Abstract][Full Text] [Related]
19. Ovarian cancer during pregnancy.
Gezginç K; Karataylı R; Yazıcı F; Acar A; Celik C; Capar M
Int J Gynaecol Obstet; 2011 Nov; 115(2):140-3. PubMed ID: 21872237
[TBL] [Abstract][Full Text] [Related]
20. Ovarian cancer. Clinical practice guidelines in oncology.
Morgan RJ; Alvarez RD; Armstrong DK; Boston B; Chen LM; Copeland L; Fowler J; Gaffney DK; Gershenson D; Greer BE; Grigsby PW; Havrilesky LJ; Johnston C; Lancaster JM; Lele S; Matulonis U; O'Malley D; Ozols RF; Remmenga SW; Sabbatini P; Schink J; Teng N;
J Natl Compr Canc Netw; 2008 Sep; 6(8):766-94. PubMed ID: 18926089
[No Abstract] [Full Text] [Related]
[Next] [New Search]
